247 related articles for article (PubMed ID: 22610269)
1. The impact of chemotherapy-related nausea on patients' nutritional status, psychological distress and quality of life.
Farrell C; Brearley SG; Pilling M; Molassiotis A
Support Care Cancer; 2013 Jan; 21(1):59-66. PubMed ID: 22610269
[TBL] [Abstract][Full Text] [Related]
2. An exploratory study to clarify the cluster of symptoms predictive of chemotherapy-related nausea using random forest modeling.
Molassiotis A; Farrell C; Bourne K; Brearley SG; Pilling M
J Pain Symptom Manage; 2012 Nov; 44(5):692-703. PubMed ID: 22672920
[TBL] [Abstract][Full Text] [Related]
3. Nausea still the poor relation in antiemetic therapy? The impact on cancer patients' quality of life and psychological adjustment of nausea, vomiting and appetite loss, individually and concurrently as part of a symptom cluster.
Pirri C; Bayliss E; Trotter J; Olver IN; Katris P; Drummond P; Bennett R
Support Care Cancer; 2013 Mar; 21(3):735-48. PubMed ID: 22976921
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy-induced nausea and vomiting in daily clinical practice: a community hospital-based study.
Hilarius DL; Kloeg PH; van der Wall E; van den Heuvel JJ; Gundy CM; Aaronson NK
Support Care Cancer; 2012 Jan; 20(1):107-17. PubMed ID: 21258948
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of using the Multinational Association of Supportive Care in Cancer Antiemesis Tool for assessment of chemotherapy-induced nausea and vomiting at the Tom Baker Cancer Centre.
Warr JK; Chambers CR; Cusano FL; Cuthbert CA; Mah MS
J Oncol Pharm Pract; 2015 Oct; 21(5):348-57. PubMed ID: 24938292
[TBL] [Abstract][Full Text] [Related]
6. Gaps exist between patients' experience and clinicians' awareness of symptoms after chemotherapy: CINV and accompanying symptoms.
Rha SY; Song SK; Lee CE; Park Y; Lee J
Support Care Cancer; 2016 Nov; 24(11):4559-66. PubMed ID: 27278273
[TBL] [Abstract][Full Text] [Related]
7. Validation and psychometric assessment of a short clinical scale to measure chemotherapy-induced nausea and vomiting: the MASCC antiemesis tool.
Molassiotis A; Coventry PA; Stricker CT; Clements C; Eaby B; Velders L; Rittenberg C; Gralla RJ
J Pain Symptom Manage; 2007 Aug; 34(2):148-59. PubMed ID: 17509816
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy-induced nausea and vomiting in clinical practice: impact on patients' quality of life.
Fernández-Ortega P; Caloto MT; Chirveches E; Marquilles R; Francisco JS; Quesada A; Suárez C; Zorrilla I; Gómez J; Zabaleta P; Nocea G; Llombart-Cussac A
Support Care Cancer; 2012 Dec; 20(12):3141-8. PubMed ID: 22460057
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the relationship between adherence with antiemetic drug therapy and control of nausea and vomiting in breast cancer patients receiving anthracycline-based chemotherapy.
Chan A; Low XH; Yap KY
J Manag Care Pharm; 2012 Jun; 18(5):385-94. PubMed ID: 22663171
[TBL] [Abstract][Full Text] [Related]
10. Anticipatory nausea among ambulatory cancer patients undergoing chemotherapy: prevalence, associated factors, and impact on quality of life.
Akechi T; Okuyama T; Endo C; Sagawa R; Uchida M; Nakaguchi T; Sakamoto M; Komatsu H; Ueda R; Wada M; Furukawa TA
Cancer Sci; 2010 Dec; 101(12):2596-600. PubMed ID: 20946120
[TBL] [Abstract][Full Text] [Related]
11. Effect of postchemotherapy nausea and vomiting on health-related quality of life. The Quality of Life and Symptom Control Committees of the National Cancer Institute of Canada Clinical Trials Group.
Osoba D; Zee B; Warr D; Latreille J; Kaizer L; Pater J
Support Care Cancer; 1997 Jul; 5(4):307-13. PubMed ID: 9257427
[TBL] [Abstract][Full Text] [Related]
12. A prospective observational study of chemotherapy-related nausea and vomiting in routine practice in a UK cancer centre.
Molassiotis A; Saunders MP; Valle J; Wilson G; Lorigan P; Wardley A; Levine E; Cowan R; Loncaster J; Rittenberg C
Support Care Cancer; 2008 Feb; 16(2):201-8. PubMed ID: 17926070
[TBL] [Abstract][Full Text] [Related]
13. Impact on daily functioning and indirect/direct costs associated with chemotherapy-induced nausea and vomiting (CINV) in a U.S. population.
Haiderali A; Menditto L; Good M; Teitelbaum A; Wegner J
Support Care Cancer; 2011 Jun; 19(6):843-51. PubMed ID: 20532923
[TBL] [Abstract][Full Text] [Related]
14. Role of psychosocial variables on chemotherapy-induced nausea and vomiting and health-related quality of life among cancer patients: a European study.
Grassi L; Berardi MA; Ruffilli F; Meggiolaro E; Andritsch E; Sirgo A; Caruso R; Juan Linares E; Bellé M; Massarenti S; Nanni MG;
Psychother Psychosom; 2015; 84(6):339-47. PubMed ID: 26402426
[TBL] [Abstract][Full Text] [Related]
15. The incidence of nausea in the absence of vomiting in patients receiving intravenous chemotherapy.
Smit T; Kotze I; du Plessis J
Ann Palliat Med; 2021 Mar; 10(3):2679-2686. PubMed ID: 33549001
[TBL] [Abstract][Full Text] [Related]
16. Quality of life consequences of chemotherapy-induced emesis.
Lindley CM; Hirsch JD; O'Neill CV; Transau MC; Gilbert CS; Osterhaus JT
Qual Life Res; 1992 Oct; 1(5):331-40. PubMed ID: 1299465
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of risk factors predicting chemotherapy-related nausea and vomiting: results from a European prospective observational study.
Molassiotis A; Aapro M; Dicato M; Gascon P; Novoa SA; Isambert N; Burke TA; Gu A; Roila F
J Pain Symptom Manage; 2014 May; 47(5):839-848.e4. PubMed ID: 24075401
[TBL] [Abstract][Full Text] [Related]
18. Rolapitant improves quality of life of patients receiving highly or moderately emetogenic chemotherapy.
Chasen M; Urban L; Schnadig I; Rapoport B; Powers D; Arora S; Navari R; Schwartzberg L; Gridelli C
Support Care Cancer; 2017 Jan; 25(1):85-92. PubMed ID: 27557833
[TBL] [Abstract][Full Text] [Related]
19. The impact of chemotherapy-induced nausea and vomiting on health-related quality of life.
Ballatori E; Roila F; Ruggeri B; Betti M; Sarti S; Soru G; Cruciani G; Di Maio M; Andrea B; Deuson RR
Support Care Cancer; 2007 Feb; 15(2):179-85. PubMed ID: 16941136
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the validity of chemotherapy-induced nausea and vomiting assessment in outpatients using the Japanese version of the MASCC antiemesis tool.
Matsuda Y; Okita K; Furuhata T; Kutomi G; Yamashita K; Sato Y; Takimoto R; Hirata K
Support Care Cancer; 2015 Nov; 23(11):3331-9. PubMed ID: 26003425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
